Ipamorelin/CJC-1295 mix
5mg+5mg
- Purity ≥99%, verified by HPLC and mass spectrometry
- 5 mg Ipamorelin + 5 mg CJC-1295 per vial
- Lyophilized powder (peptide blend)
€49.99€60.99Only 4 left
Buy more, save moreAuto-applied
1
- Free gifts from €200: sample, bacteriostatic water, full-size product
- Secure checkout · Tracked, discreet EU dispatch
Ipamorelin/CJC-1295 mix€49.99
Testing and Certificate of Analysis
Every batch is tested by an independent laboratory using HPLC and mass spectrometry before release. The Certificate of Analysis for your batch is sent on request.
- Test number
- IPA-CJC-2501-A
- Method
- HPLC + ESI-MS
- Purity target
- ≥99%
Specifications
| Form | Lyophilized powder (peptide blend) |
|---|---|
| Content | 5 mg Ipamorelin + 5 mg CJC-1295 per vial |
| Packaging | Glass vial with sterile closure |
| Storage | 2–8 °C (refrigerated), protect from light |
| Molecular Formula | Ipamorelin: C38H49N9O5 | CJC-1295: Sequence-defined peptide analog (29-aa GHRH analog) |
| Molecular Weight | Ipamorelin: ~711.85 g·mol⁻¹ | CJC-1295: ~3.3–3.4 kDa (approx., sequence-dependent) |
| Test Number | IPA-CJC-2501-A |
| IUPAC Name | Ipamorelin: sequence-defined pentapeptide amide | CJC-1295: sequence-defined GHRH analog (no simple IUPAC) |
Independently HPLC & mass-spec verified to ≥99% purity, with a Certificate of Analysis available for every batch. Supplied as a lyophilised powder in a sealed vial. Synthesised in a controlled cleanroom, sealed and dispatched discreetly and tracked across the EU, consistent, fully documented material you can rely on, batch after batch.
For laboratory research use only. Not for human or veterinary use.
